Clinical Trial Update: Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety, efficacy, and pharmacokinetics of GST-HG141 Tablets for chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• GST-HG141 Tablets

Snippet

Sponsor: Fujian Akeylink Biotechnology Co., Ltd. | Conditions: Chronic Hepatitis b | Phase 2 | Status: COMPLETED